Cargando…

Therapy Patterns and Surveillance Measures of Inflammatory Bowel Disease Patients beyond Disease-Related Hospitalization: A Claims-Based Cohort Study

INTRODUCTION: Medical care and surveillance of inflammatory bowel disease (IBD) patients have been shown to be far from satisfactory. Data on therapy patterns and surveillance measures in IBD patients are scarce. We, therefore, aimed to compare the therapy patterns and surveillance management of IBD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bähler, Caroline, Brüngger, Beat, Blozik, Eva, Vavricka, Stephan R., Schoepfer, Alain M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294938/ https://www.ncbi.nlm.nih.gov/pubmed/35979191 http://dx.doi.org/10.1159/000524741

Ejemplares similares

Trends in prevalence, mortality, health care utilization and health care costs of Swiss IBD patients: a claims data based study of the years 2010, 2012 and 2014
por: Bähler, Caroline, et al.
Publicado: (2017)

Hospital readmission risk prediction based on claims data available at admission: a pilot study in Switzerland
por: Brüngger, Beat, et al.
Publicado: (2019)

Extraintestinal Manifestations of Inflammatory Bowel Disease
por: Vavricka, Stephan R., et al.
Publicado: (2015)

Measuring diabetes guideline adherence with claims data: systematic construction of indicators and related challenges
por: Ulyte, Agne, et al.
Publicado: (2019)

Temporal trends and regional disparities in cancer screening utilization: an observational Swiss claims-based study
por: Bähler, Caroline, et al.
Publicado: (2021)

Variation of preoperative chest radiography utilization in Switzerland and its influencing factors: a multilevel study with claims data
por: Wei, Wenjia, et al.
Publicado: (2018)

Exploring geographic variation of and influencing factors for utilization of four diabetes management measures in Swiss population using claims data
por: Wei, Wenjia, et al.
Publicado: (2020)

Going beyond the mean: economic benefits of myocardial infarction secondary prevention
por: von Wyl, Viktor, et al.
Publicado: (2020)

Multimorbidity, health care utilization and costs in an elderly community-dwelling population: a claims data based observational study
por: Bähler, Caroline, et al.
Publicado: (2015)

Continuity of Care in Swiss Cancer Patients Using Claims Data
por: Blozik, Eva, et al.
Publicado: (2020)

Impact of Overweight and Obesity on Disease Outcome in the Pediatric Swiss Inflammatory Bowel Disease Cohort
por: von Graffenried, Thea, et al.
Publicado: (2022)

The impact of colectomy on the course of extraintestinal manifestations in Swiss inflammatory bowel disease cohort study patients
por: Roth, René, et al.
Publicado: (2021)

Alcohol and cannabis consumption in patients with inflammatory bowel disease: prevalence, pattern of consumption and impact on the disease
por: Martinho-Grueber, Maude, et al.
Publicado: (2022)

Benzodiazepine and Z-Drug Use in Switzerland: Prevalence, Prescription Patterns and Association with Adverse Healthcare Outcomes
por: Landolt, Salome, et al.
Publicado: (2021)

Variation of colorectal, breast and prostate cancer screening activity in Switzerland: Influence of insurance, policy and guidelines
por: Ulyte, Agne, et al.
Publicado: (2020)

Are weak or negative clinical recommendations associated with higher geographical variation in utilisation than strong or positive recommendations? Cross-sectional study of 24 healthcare services
por: Ulyte, Agne, et al.
Publicado: (2021)

Small Area Variation of Adherence to Clinical Recommendations: An Example from Switzerland
por: Gruebner, Oliver, et al.
Publicado: (2022)

Iron Formulations for the Treatment of Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease: A Cost-Effectiveness Analysis in Switzerland
por: Aksan, Aysegül, et al.
Publicado: (2020)

Anemia in Inflammatory Bowel Disease: An Under-Estimated Problem?
por: Rogler, Gerhard, et al.
Publicado: (2015)

Degree of regional variation and effects of health insurance-related factors on the utilization of 24 diverse healthcare services - a cross-sectional study
por: Wei, Wenjia, et al.
Publicado: (2020)

A Response to: Letter to the Editor Regarding ‘Iron Formulations for the Treatment of Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease: A Cost-Effectiveness Analysis in Switzerland’
por: Aksan, Aysegül, et al.
Publicado: (2021)

Effect of distance to specialist care for the diagnosis and disease outcome of inflammatory bowel disease in the Swiss inflammatory bowel disease cohort study
por: Grob, Lorenz, et al.
Publicado: (2020)

The appearance of joint manifestations in the Swiss inflammatory bowel disease cohort
por: Hiller, Aimee, et al.
Publicado: (2019)

Uveitis manifestations in patients of the Swiss Inflammatory Bowel Disease Cohort Study
por: Biedermann, Luc, et al.
Publicado: (2019)

Occurrence of skin manifestations in patients of the Swiss Inflammatory Bowel Disease Cohort Study
por: Roth, Nina, et al.
Publicado: (2019)

Colonoscopic Cancer Surveillance in Inflammatory Bowel Disease: What's New Beyond Random Biopsy?
por: East, James E.
Publicado: (2012)

Prevalence and Risk Factors for Therapy Escalation in Ulcerative Colitis in the Swiss IBD Cohort Study
por: Safroneeva, Ekaterina, et al.
Publicado: (2015)

Inflammatory bowel disease: Looking beyond the tract
por: Chams, Sana, et al.
Publicado: (2019)

Inflammatory Bowel Disease Therapy: Beyond the Immunome
por: Fiocchi, Claudio, et al.
Publicado: (2022)

Intensity of treatment in Swiss cancer patients at the end-of-life
por: Bähler, Caroline, et al.
Publicado: (2018)

Continuity of care and treatment intensity at the end of life in Swiss cancer patients
por: Bähler, Caroline, et al.
Publicado: (2023)

Risk factors for gallstones and kidney stones in a cohort of patients with inflammatory bowel diseases
por: Fagagnini, Stefania, et al.
Publicado: (2017)

The use of chromoendoscopy for surveillance of inflammatory bowel disease
por: Lichtenstein, Gary R., et al.
Publicado: (2018)

Change in Colorectal Cancer Tests Submitted for Reimbursement in Switzerland 2012–2018: Evidence from Claims Data of a Large Insurance
por: Schneider, Rémi, et al.
Publicado: (2021)

Validity of Diagnostic Algorithms for Inflammatory Bowel Disease in Japanese Hospital Claims Data
por: Takahashi, Sayumi, et al.
Publicado: (2022)

Drug-Related Adverse Events Necessitating Treatment Discontinuation in Pediatric Inflammatory Bowel Disease Patients
por: Salzmann, Medea, et al.
Publicado: (2022)

The Impact of Azathioprine-Associated Lymphopenia on the Onset of Opportunistic Infections in Patients with Inflammatory Bowel Disease
por: Vögelin, Marius, et al.
Publicado: (2016)

Colorectal cancer screening and surveillance in patients with inflammatory bowel disease in 2021
por: Huguet, Jose Maria, et al.
Publicado: (2022)

Colon Cancer Screening and Surveillance in Inflammatory Bowel Disease
por: Bae, Song I, et al.
Publicado: (2014)

Validation of claims-based indicators used to identify flare-ups in inflammatory bowel disease
por: Burisch, Johan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_88q7p9rukk81p0j5ac7n6843ci